Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Moccia

Showing results (51-60 of 221) with videos related to

Pageof 23
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 3, 2025
Neural networks to estimate multiple sclerosis disability and predict progression using routinely collected healthcare dataGiuseppina Affinito, Marcello Moccia, Roberta Lanzillo, et al.
Parkinsonism & Related Disorders|January 12, 2013
Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: report of 2 casesCarmine Vitale, Gabriella Santangelo, Roberto Erro, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosisAntonio Carotenuto, Elisabetta Signoriello, Roberta Lanzillo, et al.
Brain Sciences|October 2, 2019
Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10Marcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.
BMC Health Services Research|August 28, 2020
Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)Marcello Moccia, Ilaria Loperto, Roberta Lanzillo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2026
A proof-of-concept study on the effectiveness of botulinum toxin on spasticity plus syndrome in multiple sclerosisMarcello Moccia, Chiara Clemente, Simone Braca, et al.
Expert Opinion on Drug Delivery|September 16, 2015
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosisMarcello Moccia, Raffaele Palladino, Cinzia Russo, et al.
Parkinsonism & Related Disorders|May 10, 2016
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson diseaseRoberto Erro, Marina Picillo, Carmine Vitale, et al.
Parkinsonism & Related Disorders|April 13, 2016
Gender and non motor fluctuations in Parkinson's disease: A prospective studyMarina Picillo, Raffaele Palladino, Marcello Moccia, et al.
JAMA Neurology|November 27, 2013
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsyRoberto Erro, Andrew J Lees, Marcello Moccia, et al.
Pageof 23

Showing results (51-60 of 221) with videos related to

Sort By:
Pageof 23
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 3, 2025
Neural networks to estimate multiple sclerosis disability and predict progression using routinely collected healthcare dataGiuseppina Affinito, Marcello Moccia, Roberta Lanzillo, et al.
Parkinsonism & Related Disorders|January 12, 2013
Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: report of 2 casesCarmine Vitale, Gabriella Santangelo, Roberto Erro, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosisAntonio Carotenuto, Elisabetta Signoriello, Roberta Lanzillo, et al.
Brain Sciences|October 2, 2019
Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10Marcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.
BMC Health Services Research|August 28, 2020
Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)Marcello Moccia, Ilaria Loperto, Roberta Lanzillo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2026
A proof-of-concept study on the effectiveness of botulinum toxin on spasticity plus syndrome in multiple sclerosisMarcello Moccia, Chiara Clemente, Simone Braca, et al.
Expert Opinion on Drug Delivery|September 16, 2015
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosisMarcello Moccia, Raffaele Palladino, Cinzia Russo, et al.
Parkinsonism & Related Disorders|May 10, 2016
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson diseaseRoberto Erro, Marina Picillo, Carmine Vitale, et al.
Parkinsonism & Related Disorders|April 13, 2016
Gender and non motor fluctuations in Parkinson's disease: A prospective studyMarina Picillo, Raffaele Palladino, Marcello Moccia, et al.
JAMA Neurology|November 27, 2013
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsyRoberto Erro, Andrew J Lees, Marcello Moccia, et al.
Pageof 23